Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,297Revenue (TTM) $M3,084Net Margin (%)12.8Altman Z-Score4.3
Enterprise Value $M29,292EPS (TTM) $1.8Operating Margin %21.6Piotroski F-Score5
P/E(ttm)68.9Beneish M-Score-2.6Pre-tax Margin (%)18.7Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales8.95-y EBITDA Growth Rate %26.5Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow36.3y-y EBITDA Growth Rate %42.7ROA % (ttm)3.0Higher Current Ratio y-yN
Dividend Yield %--PEG2.6ROE % (ttm)4.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M225ROIC % (ttm)4.3Gross Margin Increase y-yY

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ALXN is held by these investors:

ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Neill JulieEVP. Global Operations 2017-03-02Sell651$133.8-9.9view
Moriarty John BEVP & General Counsel 2017-03-01Sell1,804$131.66-8.44view
MACKAY MARTINEVP & Global Head of R&D 2017-03-01Sell1,855$131.63-8.42view
Carmichael ClareEVP, Chief HR Officer 2017-03-01Sell2,179$131.66-8.44view
Wagner Heidi LSVP, Global Government Affairs 2017-03-01Sell994$131.65-8.43view
BELL LEONARDDirector 2017-03-01Sell3,978$131.96-8.65view
O'Neill JulieEVP. Global Operations 2017-02-28Sell1,574$131.41-8.26view
Miller EdwardSVP, Chief Compliance Officer 2017-02-28Sell590$131.48-8.31view
Thiel CarstenEVP, Chief Commercial Officer 2017-02-28Sell125$74.5261.77view
Thiel CarstenEVP, Chief Commercial Officer 2017-02-28Sell3,783$131.01-7.98view

Press Releases about ALXN :

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidat Mar 16 2017 
Spiros Segalas on Alexion Pharmaceuticals Aug 18 2016 
Spiros 'Sig' Segalas' Capital Appreciation Fund 2nd Quarter Commentary Nov 07 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 06 2016 
Baron Funds Comments on Alexion Pharmaceuticals Feb 08 2016 
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals Jan 03 2016 
Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences Dec 13 2015 

More From Other Websites
Is This Why Akari Therapetuics PLC Is Falling Today? Apr 24 2017
Street Watches To See If $125,000 Drug Boosts Biogen's Results Apr 21 2017
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise? Apr 21 2017
What to expect from biotech Apr 20 2017
Gilead Sciences: Who's Frustrated Now? Apr 19 2017
3 Beaten-Up Healthcare Stocks: Are They Bargains? Apr 19 2017
The 7 Most Expensive Prescription Drugs in the World Apr 18 2017
3 Big Reasons to Be Bullish on Biotech Stocks Apr 16 2017
The Hot Stock: Alexion Pharmaceuticals Climbs 3.3% Apr 13 2017
[$$] Celgene, Biogen to Gain From Higher Prices Apr 12 2017
Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017 Apr 06 2017
Alexion Pharmaceuticals Slid 9.9% in March -- but Why? Apr 04 2017
[$$] Beaten-Down Biotechs May Be Worth Buying Apr 04 2017
3 Top Growth Stocks Priced at a Bargain This Spring Apr 03 2017
Akari Gets Fast Track Status for Coversin Drug Mar 31 2017
Which Biotechs Are Buyable As Sector Recovers In 2017? Mar 30 2017
Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study Mar 29 2017
Here's Why Omeros Corporation Stock Climbed Higher Today Mar 28 2017
[$$] Alexion Names New CEO Following Internal Sales-Practice Probe Mar 27 2017
Alexion Pharma names former Baxalta chief Ludwig Hantson CEO Mar 27 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)